German company BioNTech, which in partnership with Pfizer developed one of the most widely used anti-Covid shots, says it’s preparing for the worldwide launch of its jab for younger recipients and might get approval in October. … Read More >BioNTech ‘preparing production’ of Covid-19 vaccine for children under 12, which may be approved in Europe next month – media
